Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-01-09 @ 3:53 PM
Study NCT ID:
NCT03604692
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2018-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
Sponsor:
Syndax Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-10
First Submit QC Date:
None
Study First Post Date:
2018-07-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-12
Results First Submit QC Date:
None
Results First Post Date:
2024-11-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-11-27
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-08-25
Last Update Post Date:
2025-09-15
Last Update Post Date Type:
ESTIMATED